Investment Summary

Maven Capital Partners Invests In Blacktrace

On April 1, 2016, asset manager Maven Capital Partners invested in medical products company Blacktrace

Investment Highlights
  • This is Maven Capital Partners’ 1st transaction in the Medical Products sector.
  • This is Maven Capital Partners’ 74th transaction in the United Kingdom.
Investment Fate
  • Blacktrace was sold to a strategic buyer in 2023.

Investment Summary
Date 2016-04-01
Target Blacktrace
Sector Medical Products
Investor(s) Maven Capital Partners
Deal Type Growth Capital

Target

Blacktrace

Royston, United Kingdom
website
Blacktrace designs, develops and manufactures cutting-edge technologies and products for many applications in chemistry, microfluidics, biology, and nanomaterial sciences. Blacktrace was founded in 2001 and is based in Royston, United Kingdom.

Search 195,609 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Maven Capital Partners

Glasgow, United Kingdom

Investor Investor Investor Investor Investor

website

Category Asset Manager
Founded 2009
PE ASSETS 415M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Maven Capital Partners UK LLP (MCP) invests in lower mid-market companies throughout the UK. The Firm also provides mezzanine financing. MCP focuses on profitable companies with proven track records, balanced management teams, and diverse products and services. Maven looks to invest £2 - £10 million in businesses valued from £5 - £25 million. Sectors of interest include specialist manufacturing, health/pharmaceuticals, energy services, leisure, financial services, software and computer services, communication/IT, chemicals, food/beverage, media, consumer products, and support services. Types of transactions include MBOs, MBIs, BIMBOs, take privates, recapitalizations, and growth capital financings. Maven Capital Partners UK LLP was formed in 2009, following a management buyout of Aberdeen Asset Management's Private Equity division. Maven is based in Glasgow with additional offices in Aberdeen, Birmingham, Edinburgh, London and Manchester.

DEAL STATS #
Overall 75 of 199
Sector (Medical Products) 1 of 2
Type (Growth Capital) 41 of 150
Country (United Kingdom) 74 of 194
Year (2016) 3 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-10 Plethora Solutions Holdings

London, United Kingdom

Plethora Solutions Holdings PLC is a specialist pharmaceutical business focused on developing products for the treatment and management of urological disorders. Plethora was founded in 2003, before being listed on AIM in 2005. The company has grown in response to increasing demand for its products which serve a large, growing patient population whose medical needs are currently poorly met. Plethora has grown from a cash consumptive development company into a sustainable urology business benefiting from both near term product sales and high value, medium term licensing income.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-04-10 Westfield Medical

Radstock, United Kingdom

Westfield Medical is a provider sterilization pouch, reels, bags, wraps, tray liners, Humipak, count sheets, autoclave tape, and Bowie & Dick + test packs to the healthcare and industrial sectors. Westfield Medical was founded in 1992 and is based in Radstock, United Kingdom.

Buy £12M
Mergr

Product

Company

Legal